Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-17
1989-11-21
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
048823368
ABSTRACT:
A method of treating demyelinization clinical patterns of autoimmune origin, particularly multiple sclerosis. The pharmaceutical composition makes use of ethyl (+)-apovincaminate as the active ingredient.
REFERENCES:
patent: 4382936 (1983-05-01), Katsube et al.
Bozoky Bela
Forgacs Lilla
Frank Tibor
Hajos Gyorgy
Szegvari Zsuzsanna
Dubno Herbert
Fay Zohreh A.
Myers Jonathan
Richter Gedeon Vegyeszeti Gyar Rt.
Robinson Douglas W.
LandOfFree
Method and pharmaceutical composition for treating leukoencephal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and pharmaceutical composition for treating leukoencephal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and pharmaceutical composition for treating leukoencephal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1426246